Cargando…
Safety and effectiveness of dulaglutide 0.75 mg in Japanese patients with type 2 diabetes in real‐world clinical practice: 36 month post‐marketing observational study
AIMS/INTRODUCTION: This study evaluated the safety and effectiveness of dulaglutide in patients with type 2 diabetes in the real‐world setting in Japan. MATERIALS AND METHODS: This prospective, observational post‐marketing surveillance study was conducted for 36 months (July 2016 to July 2021) in Ja...
Autores principales: | Chin, Rina, Nagaoka, Soshi, Nakasawa, Haru, Tanaka, Yoko, Inagaki, Nobuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889676/ https://www.ncbi.nlm.nih.gov/pubmed/36367417 http://dx.doi.org/10.1111/jdi.13932 |
Ejemplares similares
-
The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2016) -
Acridine 0.75-hydrate
por: Schur, Einat, et al.
Publicado: (2011) -
The efficacy of 0.75% levobupivacaine versus 0.75% ropivacaine for peribulbar anesthesia in vitreoretinal surgery
por: Ghali, Ashraf M.
Publicado: (2012) -
A Comparative Study between Intrathecal Isobaric Ropivacaine 0.75% Plus Dexmedetomidine and Isobaric Ropivacaine 0.75% Plus Fentanyl for Lower Limb Surgeries
por: Ravipati, Prabhavathi, et al.
Publicado: (2017) -
Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle‐controlled, phase 3 study
por: Miyachi, Yoshiki, et al.
Publicado: (2021)